Smaller Ca 2ϩ transients and systolic dysfunction in heart failure (HF) can be largely explained by reduced total sarcoplasmic reticulum (SR) Ca 2ϩ content ([Ca] SRT ). However, it is unknown whether low [Ca] SRT is manifest as reduced:
D efective intracellular Ca 2ϩ handling may play a central pathophysiological role in heart failure (HF). 1 Contractile dysfunction in end-stage HF has been attributed to reduced Ca 2ϩ transients, which could be caused by decreased Ca 2ϩ current (I Ca ), reduced excitation-contraction coupling efficacy between I Ca , and sarcoplasmic reticulum (SR) Ca 2ϩ release (excitation-contraction coupling) 2, 3 or reduced SR Ca 2ϩ load ([Ca] SRT ). 4 -6 Most studies find that peak I Ca,L density and fractional SR Ca 2ϩ release are not depressed in HF, 4 -6 despite lower [Ca] SRT , which by itself would tend to reduce fractional SR Ca 2ϩ release. [7] [8] [9] [10] Lower [Ca] SRT has been shown in animal HF models and also in human HF. 4 -6,11-13 This is caused by reduced SR Ca 2ϩ -ATPase (SERCA) function, increased Na ϩ -Ca 2ϩ exchange (NCX) function, and increased SR Ca 2ϩ leak (to different extents in different HF models; see the online data supplement at http://circres.ahajournals.org). 4 -6,11-15 Although these changes in Ca 2ϩ transport cause the reduced [Ca] SRT in HF, the reduced [Ca] SRT could be manifest as (1) reduced free SR Ca 2ϩ ([Ca 2ϩ ] SR ) throughout the SR, which could decrease the driving force for SR Ca 2ϩ release and ryanodine receptor (RyR) activation by luminal Ca 2ϩ ; (2) reduced intra-SR Ca 2ϩ buffering capacity; and/or (3) reduced volume percent of cell occupied by SR (with normal [Ca 2ϩ ] SR ). 16 To distinguish among these possibilities, one needs to directly measure [Ca 2ϩ ] SR and intra-SR Ca 2ϩ buffering in intact ventricular myocytes in HF versus control, which has not been done previously (even in control myocytes).
The present study aimed to assess the aforementioned manifestations of reduced [Ca] SRT in HF. We measured [Ca 2ϩ ] SR and intra-SR Ca 2ϩ buffering in a well-characterized rabbit model of nonischemic HF (induced by aortic insufficiency and aortic constriction). 5, 15, 17 These HF rabbits exhibit nonsustained ventricular tachycardias (90%, with 10% incidence of sudden death), a 2-fold functional overexpression of NCX, and myocytes have reductions in contraction, Ca 2ϩ transient amplitude, and [Ca] SRT . Here we measured [Ca 2ϩ ] SR , [Ca] SRT , and [Ca 2ϩ ] i simultaneously in ventricular myocytes using the low-affinity Ca 2ϩ indicator fluo-5N (for [Ca 2ϩ ] SR ) 18 and fura-2 (for [Ca 2ϩ ] i ). We found that the reduction in [Ca] SRT in HF can be explained by reduced [Ca 2ϩ ] SR , without substantial changes in either intra-SR buffering or inferred SR volume percentage.
Materials and Methods

Rabbit HF Model and Cardiac Myocyte Isolation
Studies were performed on myocytes isolated as previously described 1 from control (nϭ15) and HF (nϭ9) adult New Zealand White rabbits of either sex. HF was induced by combined aortic insufficiency and aortic constriction as described 5, 17 and studied Ϸ6 months later. Protocols were approved by Animal Studies Committees of Loyola University Chicago and University of Illinois at Chicago. Additional methodological details are in the online data supplement.
Fluorescent Measurement of [Ca 2؉ ] SR and In Vivo Calibration
Isolated ventricular myocytes were loaded with 10 mol/L fluo-5N acetoxymethyl ester (Molecular Probes). 18 Experiments were performed at 23°C on an epifluorescence microscope. F max was determined for each cell as described. 18 After stimulation at 1 Hz with 1 mol/L isoproterenol, 0.5 mmol/L tetracaine was added to block SR Ca 2ϩ leak and extracellular Na ϩ was removed to raise [Ca 2ϩ ] SR via NCX and SERCA. Fluorescence during 10 mmol/L caffeine application depleted [Ca] SRT and was defined as F min (or F caff ), and all fluorescence signals were after F caff subtraction. Caffeine-sensitive diastolic fluorescence at 0.5 Hz was defined as F 0 , and [Ca 2ϩ ] SR at 0.5 18 Fluorescence signals for data analysis were averaged from 4 transients.
Western Blot Analysis
Left ventricular tissue from control and HF rabbits were subjected to Western blotting 15 using primary antibodies to calsequestrin (CSQ) (Santa Cruz Biotechnology) and GAPDH (Chemicon).
Fluorescent Measurements of [Ca 2؉ ] i and SR Ca 2؉ Load [Ca] T
Myocytes were loaded with fura-2 acetoxymethyl ester, and fura-2 was excited at 340Ϯ10 and 380Ϯ10 nm, and emission (535Ϯ20 nm) was recorded at 100 Hz. Background-subtracted fluorescence ratio (RϭF 340 /F 380 ) was converted to [Ca 2ϩ ] i , and [Ca] SRT was relative to nonmitochondrial cell volume (see the online data supplement). 7, 8, 19 
SERCA Ca 2؉ Flux Analysis
Instantaneous SERCA-mediated Ca 2ϩ flux (J SR ) was calculated, where [Ca 2ϩ ] i and [Ca 2ϩ ] SR were measured simultaneously:
where K mf and K mr are K m values for forward and reverse SERCA fluxes, respectively; k is the rate constant for leak flux (J leak ); V max is maximum flux rate; and H is Hill coefficient. For control myocytes, parameters are used as previously described. 19, 20 In HF, V max was reduced by 20% (as in our experiments, see under Results) and k was adjusted to obtain Ϸ4 mol/L sec Ϫ1 J leak at diastolic [Ca 2ϩ ] SR at 0.5 Hz (when [Ca 2ϩ ] SR Ϸ630 mol/L; see under Results). 13 Alternatively 
Statistical Analysis
The data are meansϮSEM. Significant differences were assessed using Student t test at PϽ0.05. Figure 1 shows Ca 2ϩ transients in control and HF myocytes. Consistent with prior work using this HF model, 5, 17 Ca 2ϩ transient amplitude was reduced in HF versus control at 0.5 and 1 Hz stimulation (by 25% and 57%, respectively; Figure  1C ), but diastolic [Ca 2ϩ ] i was unaltered (116Ϯ15 nmol/L in HF, 140Ϯ17 nmol/L in control). After steady-state pacing at 0.5 and 1 Hz, caffeine-induced Ca 2ϩ transients also showed [Ca] SRT reduction by 24% and 30% in HF versus control (PϽ0.05; Figure 1B and 1D).
Results
Characterization of Stimulated and Caffeine-Induced Ca 2؉ Transients
The rate of [Ca 2ϩ ] i decline during caffeine application depends mainly on NCX-mediated Ca 2ϩ extrusion, whereas twitch [Ca 2ϩ ] i decline is more SERCA dependent in rabbit myocytes. 17, 21 The mean time constant () of NCX-mediated [Ca] i decline ( caff ϭ NCX ) was faster in HF versus control (1.3Ϯ0.1 versus 2.0Ϯ0.1 s) after 0.5 Hz of stimulation ( Figure 1E ). However, twitch ( twitch ) was similar (636Ϯ54 ms in HF versus 670Ϯ60 ms in control). If twitch [Ca] i decline is attributed to parallel SERCA and NCX function and k is the rate constant (kϭ1/), then k twitch ϭk SR ϩk NCX . 17 In HF myocytes, k twitch ϭ1.70Ϯ0.09 sec Ϫ1 and k NCX ϭ0.81Ϯ0.07 sec Ϫ1 , whereas in control myocytes, k twitch ϭ1.69Ϯ0.16 sec Ϫ1 and k NCX ϭ0.54Ϯ0.03 sec Ϫ1 . This indicates a 23% reduction in SERCA function (k SR ϭ0.89 versus 1.15 sec Ϫ1 , HF versus control) but a 50% increase in NCX function. Therefore, enhanced NCX activity in HF compensates for SERCA to allow unaltered rate of twitch [Ca 2ϩ ] i decline overall (whereas both effects contribute to reduced [Ca] SRT ). 13 Figure 1F shows the [Ca 2ϩ ] i dependence of transport, indicating that (as a function of [Ca 2ϩ ] i ) overall Ca 2ϩ removal (by SERCAϩNCX) was comparable in control and HF, but SR and NCX transport were more evenly balanced in HF, consistent with previous studies in this HF model. 17
Decreased [Ca 2؉ ] SR in HF Myocytes
To test whether [Ca 2ϩ ] SR is decreased in HF, we measured [Ca 2ϩ ] i and [Ca 2ϩ ] SR simultaneously using fura-2 and fluo-5N. 18 Figure 2A shows typical fluorescence changes during twitches and caffeine-induced Ca 2ϩ transients. When [Ca 2ϩ ] i transiently rises (top), fluo-5N fluorescence transiently decreases (bottom). F min is taken as F caff , whereas F 0 is the caffeine-sensitive diastolic fluo-5N fluorescence at 0.5 Hz (F d-0.5Hz ). To calibrate fluo-5N signals, maximal fluorescence (F max ) was measured in situ from the same myocyte ( Figure  2B ). Briefly, isoproterenol was first added at 1 Hz (which by itself caused fluorescence to approach F max in control myocytes; compare Figure 2A and 2B). Then RyR Ca 2ϩ release was inhibited by 0.5 mmol/L tetracaine, and finally Na ϩ -free solution was applied. This protocol pushes SERCA toward its thermodynamic limit. 18 Figure 2B (top) shows that tetracaine initially blocked SR Ca 2ϩ release, but massive SR Ca 2ϩ loading induced by Na ϩ -free solution allowed some SR Ca 2ϩ release (see Figure 2B , top). Despite this, intra-SR fluorescence (F/F 0 ; Figure 2B , bottom) did not further increase, indicating saturation of intra-SR fluo-5N (taken as F max , after correcting for fluorescence quench by tetracaine).
Guo et al Decreased [Ca] SR but Unaltered SR Buffering in HF
F max was measured in each HF and control myocyte (1.76Ϯ0.15ϫF 0 in HF, 1.54Ϯ0.09ϫF 0 in control; Pϭ0.26). The higher F max /F 0 in HF myocytes directly indicated that at 0.5 Hz, intra-SR fluo-5N was less saturated in HF versus control myocytes (57% versus 65%) and that [Ca 2ϩ ] SR was lower in HF (regardless of absolute calibrations). Figure 3A shows normalized representative cytosolic and intra-SR Ca 2ϩ transients (with SR signal inverted). When the raw signals were superimposed, kinetic differences were apparent (left). However, when both signals were calibrated in micromoles per liter, there was less disparity in kinetics. This is likely attributable to the fura-2 signal being fairly linear versus [Ca] i (except near the Ca 2ϩ transient peak) and fluo-5N being in the nonlinear range (above K d ) for most of the excursion (and least so at the [Ca 2ϩ ] SR nadir). Although some discrepancy might be expected, calibrated signals are required for such comparisons. Figure 3B and 3C illustrates calibrated [Ca 2ϩ ] SR signals at 2 pacing rates in control and HF myocytes. In control, doubling frequency increased both diastolic [Ca 2ϩ ] SR and the extent of [Ca 2ϩ ] SR depletion, but in HF, neither diastolic [Ca 2ϩ ] SR nor depletion significantly changed (and we saw no distinct net diastolic leak phase in steady-state [Ca 2ϩ ] SR traces). Figure 4A shows how diastolic [Ca 2ϩ ] SR and [Ca] SRT were simultaneously measured using diastolic fluo-5N and caffeine-induced fura-2 transients. To test whether fluo-5N significantly affects SR Ca 2ϩ load (as an additional intra-SR buffer), we compared the [Ca] SRT in myocytes with both fura-2 plus fluo-5N or fura-2 alone ( Figure 4A , bottom). Fluo-5N did not affect [Ca] SRT assessed by fura-2 and, therefore, was not a major SR Ca 2ϩ buffer (consistent with our recent estimate using this approach 22 that intra-SR [fluo-5N] is Ϸ50 mol/L or Ϸ1% of expected endogenous SR Ca 2ϩ -binding sites). Figure 4B shows that at very low frequency (0. The extent of [Ca 2ϩ ] SR depletion (in micromoles per liter) during the twitch also increased progressively with frequency in control myocytes ( Figure 4C ) but was significantly blunted in HF. The same applied for the fractional [Ca 2ϩ ] SR depletion ( Figure 4D ). This is consistent with the less positive forcefrequency relationships typical of human HF. 1, 11 Although positive feedback in Ca 2ϩ -induced Ca 2ϩ release might be expected to empty the SR, Figure 4E shows that SR Ca 2ϩ release terminated when [Ca 2ϩ ] SR dropped to 0.3 to 0.5 mmol/L during systole in both nonfailing and HF myocytes. Clearly, complete SR Ca 2ϩ depletion is not required to terminate release. A possible mechanism of release termination is that as luminal [Ca 2ϩ ] declines, approaching 0.3 to 0.5 mmol/L, release turns off because of the regulatory effect of [Ca 2ϩ ] SR on RyR gating. 7, 8, [23] [24] [25] However, Figure 4E also shows that the minimum twitch [Ca 2ϩ ] SR increased with frequency in control myocytes (Pϭ0.0025, 1-way ANOVA). Thus, there was not a strict [Ca 2ϩ ] SR at which release shuts off. Possibly the higher [Ca 2ϩ ] SR driving force and initial rate of Ca 2ϩ release may raise cleft [Ca 2ϩ ] to a higher level, where cytosolic Ca 2ϩ -dependent RyR inactivation may also contribute to release termination (before [Ca 2ϩ ] SR reaches 0.3 mmol/ L). 18 The unaltered minimum twitch [Ca 2ϩ ] SR in HF cells ( Figure 4E ) may thus relate to the limited increase in SR Ca 2ϩ release at higher frequency. At 0.1 Hz in control and all 3 frequencies in HF, release terminated at approximately the same [Ca 2ϩ ] SR . Thus, there may be unaltered regulation of RyR by [Ca 2ϩ ] SR in HF. Figure 4F shows SR Ca 2ϩ release duration (time to minimum [Ca 2ϩ ] SR ). In control, release duration was nearly constant for all frequencies. However, in HF, release was significantly prolonged versus control (especially at low frequency). Speculatively, the slower Ca 2ϩ release in HF (attributable to lower [Ca 2ϩ ] SR ) might prolong the time required to reach the shutoff value of [Ca 2ϩ ] SR , or altered release kinetics (eg, via Ca 2ϩ /camodulin-dependent kinase [CaMK]II) may prolong release. 26 Figure 5A assesses how [Ca 2ϩ ] SR influences SR Ca 2ϩ release in control and HF myocytes. At low [Ca 2ϩ ] SR , Ca 2ϩ release is very small (in either control or HF myocytes). The control data were fit with a Hill curve, where fractional SR Ca 2ϩ release increased to a maximum (82%) as a function of [Ca 2ϩ ] SR with half-maximal activation (K act ) of 1.2 mmol/L and Hill coefficient 2.2. Using the same maximal fractional release and Hill coefficient, the K act for HF myocytes was lower (762 mol/L). This suggests that for a given [Ca 2ϩ ] SR (or [Ca] SRT ), fractional SR Ca 2ϩ release is actually higher in HF than in control. Figure 5B plots the fractional SR Ca 2ϩ release (percentage decline in [Ca 2ϩ ] SR ), which increases with increasing [Ca 2ϩ ] SR . This is evidence for activation (or sensitization) of release by [Ca 2ϩ ] SR . Moreover, the simplest fit linear regression was steeper for HF myocytes. Additionally, the dotted curves are from the Hill functions in Figure 5A (as fractional SR Ca 2ϩ release). Clearly, the release process is sensitized in HF. This may explain the relatively unaltered fractional SR Ca 2ϩ release in HF versus control in Figure 4D 
[Ca 2؉ ] SR Dependence of SR Ca 2؉ Release
Unaltered Intra-SR Ca 2؉ Buffering in HF Myocytes
To test whether HF alters intra-SR Ca 2ϩ buffering, [Ca] SRT was varied by pacing frequency, and diastolic [Ca 2ϩ ] SR and [Ca] SRT were both measured (as in Figure 4A ). Figure 6A shows that [Ca] SRT as a function of [Ca 2ϩ ] SR was similar in HF versus control myocytes. Note that cytosolic Ca 2ϩ buffering was also unaltered in this HF model, 5 as well as in human HF and a canine HF model. 6, 27 Here we estimated intra-SR Ca 2ϩ buffering B max using [Ca] SRT and [Ca 2ϩ ] SR (see Materials and Methods). This yielded similar B max in HF and control myocytes (135.8Ϯ9.4 versus 125.8Ϯ11.5 mol/L cytosol, respectively; Pϭ0.5). We also compared CSQ expression level ( Figure 6B ) and found no significant difference between the 2 groups (consistent with our functional results). Thus, the concentration of total effective intra-SR Ca 2ϩ -binding sites was unaltered in HF myocytes.
Assuming that SRϭ3.5% of total cell volume, then B max is 2.34 and 2.53 mmol/L SR in HF and control, respectively. This is close to our previous estimation of B max of 2.7 mmol/L SR volume. 20 So far, we measured decreased diastolic [Ca 2ϩ ] SR and [Ca] SRT and unaltered SR buffering in HF. We did not directly assess SR volume percentage in HF, but it is unlikely to be a major factor for 2 reasons. First, neither [ 
SERCA Ca 2؉ Flux Analysis
To further test our measurements and interpretations, we analyzed SR Ca 2ϩ flux 3 ways in control and HF myocytes, using our measured mean data and some parameters from our previous studies. 13, 20 First, we calculated SERCA flux assuming J SR1 ϭJ Twitch ϪJ NCX and J Rel ϭ0, using the cytosolic Ca 2ϩ transient decline (converted to total [Ca] i ). 19 By integrating Ca 2ϩ removal fluxes through the SR pump and NCX versus time, we calculated how these systems competed dynamically and simultaneously during a normal twitch. Figure 7A shows the fractions of Ca 2ϩ transported by SERCA and NCX were 66% and 34%, respectively, in control myocytes, which agrees with our previous work. 21 Figure 7B shows J SR1 along with 2 other flux analysis methods. For the second method, J SR2 was calculated using both [Ca 2ϩ ] i and the simultaneously measured [Ca 2ϩ ] SR inserted into Equation 1 (see Materials and Methods). The time course of integrated J SR2 matched J SR1 rather well. The third method depends solely on the measured [Ca 2ϩ ] SR and intra-SR buffering (as in Figure 6A ). Thus, J SR3 is a simple function of [Ca 2ϩ ] SR , K d-SR , and B max-SR . Although the J SR3 integral rose a bit faster than for J SR1 and J SR2 for control myocytes, they had similar kinetics in HF myocytes. These same 3 methods are shown for HF myocytes (Figure 7C ). Based on all 3 methods, steady-state Ca 2ϩ removal by SERCA was decreased by Ϸ25% in HF, which is consistent with Ϸ23% reduction in SERCA pump function in this HF model ( Figure 1F here and our prior work). 5, 17 Overall, it is remarkable that 3 different analytical methods to determine J SR (which use different assumptions and data) lead to very similar curves. This gives us more confidence in the reliability of our quantitative SR Ca 2ϩ flux analyses and our conclusion that reduced [Ca 2ϩ ] SR (not intra-SR Ca 2ϩ buffering or volume percentage) is responsible for the decreased [Ca] SRT in HF.
Discussion
In the present study, we compared [Ca 2ϩ ] SR and intra-SR buffering in a well-characterized rabbit model of nonischemic HF versus control, using simultaneous measurement of [Ca 2ϩ ] i and [Ca 2ϩ ] SR . We found that (1) 
[Ca] SRT and [Ca 2؉ ] SR in HF: Comparison With Previous Study
There is some consensus that [Ca] SRT is reduced in HF and that altered function of SERCA, NCX, and RyR-mediated leak are responsible (see the online data supplement for mechanistic discussion). 1,13.17 Here we measured, for the first time, how reduced [Ca] SRT is manifested, whether it is attributable to reduced [Ca 2ϩ ] SR , intra-SR buffering, or the volume percentage of SR in HF myocytes. 16 This is an important distinction, because it could guide novel therapeutic strategies. Among these possibilities, reduced [Ca 2ϩ ] SR is particularly critical, because [Ca 2ϩ ] SR determines the driving force for SR Ca 2ϩ release, total SR Ca 2ϩ content, fractional Ca 2ϩ release, and regulation of RyR open probability.
Kubalova et al 14 used fluo-5N to probe [Ca 2ϩ ] SR in a canine tachypacing-induced HF model. They found that fluo-5N fluorescence was lower in HF myocytes, but they did not measure F max or otherwise calibrate the signal. This is a crucial limitation because fluo-5N is a single-wavelength indicator with a fluorescence that is affected by its concentration, distribution, and compartmentalization (eg, differential indicator loading), and its fluorescence is a nonlinear function of [Ca 2ϩ ] SR in the range of interest. 18 Here we provide the first direct on-line measurements of [Ca 2ϩ ] SR in HF myocytes.
We show that in HF myocytes diastolic [Ca 2ϩ ] SR and twitch ⌬[Ca 2ϩ ] SR were reduced in HF myocytes during stimulation at 0.5 to 1 Hz. This could explain why in HF there is reduced [Ca] SRT , smaller twitch Ca 2ϩ transients and contractions, and a blunted force-frequency (especially at higher heart rates). 1 We suspect that CaMKII-dependent enhancement of SR Ca 2ϩ leak might be critical in limiting [Ca] SRT in the forcefrequency relationship in HF (see the online data supplement). This decreased [Ca 2ϩ ] SR in HF is expected to reduce fractional SR Ca 2ϩ release because of the steep relationship between [Ca] SRT and fractional SR Ca 2ϩ release 7-10 and sensitivity of RyR gating to [Ca 2ϩ ] SR in bilayer studies. 28 Because small reductions in [Ca] SRT can substantially reduce fractional SR Ca 2ϩ release, it was surprising that fractional release was only modestly changed in HF ( Figure 4D ). However, this is consistent with analysis of SR Ca 2ϩ release in Figure 5 , where for a given [Ca 2ϩ ] SR , there was a higher fractional SR Ca 2ϩ release in HF. It is also in line with less direct estimates of fractional SR Ca 2ϩ release in this rabbit HF model and in human HF myocytes, which are unchanged despite 40% to 50% reduction in [Ca] SRT . 5, 6 We suspect that this sensitization may be partly because there is substantial upregulation and activation of CaMKII and RyR phosphorylation in HF, 15, 29, 30 which can enhance fractional SR Ca 2ϩ release for a given [Ca] SRT and Ca 2ϩ current trigger. 31 Despite this sensitization of release, the amount of SR Ca 2ϩ release was still significantly reduced in HF ( Figures 1A and 1C and 4B and 4C). That is, reduced [Ca 2ϩ ] SR tends to lower fractional SR Ca 2ϩ release in HF, but sensitization increases this fraction back toward control (despite persistently low [Ca 2ϩ ] SR and Ca 2ϩ transient amplitudes).
Regulation of RyR gating by [Ca 2ϩ ] SR may also contribute to the shutoff of SR Ca 2ϩ release during excitation-contrac-tion coupling. 23 That is, in all HF cells and control cells at 0.1 Hz, release terminated at [Ca 2ϩ ] SR of 0.3 to 0.4 mmol/L ( Figure 4E) , regardless of what [Ca 2ϩ ] SR was before release ( Figure 4A) . Thus, at this [Ca 2ϩ ] SR , the RyR may be effectively deactivated (or even inactivated). Indeed, increased exogenous low-affinity Ca 2ϩ buffer in the SR (which slows [Ca 2ϩ ] SR decline) prolongs release time. 23, 24 At our larger initial [Ca 2ϩ ] SR and SR Ca 2ϩ release (control myocytes at 0.5 to 1 Hz), release terminated before [Ca 2ϩ ] SR fell to 0.3 to 0.4 mmol/L. This might be a manifestation of Ca 2ϩ -dependent cytosolic inactivation. That is, with more SR Ca 2ϩ release, local [Ca 2ϩ ] i -dependent inactivation could become more important, terminating release before [Ca 2ϩ ] SR falls to 0.3 to 0.4 mmol/L.
Intra-SR Buffering in HF
Ca 2ϩ is heavily buffered in the SR, and CSQ is the most prominent SR Ca 2ϩ buffer (with a Ca 2ϩ affinity of Ϸ0.6 mmol/L). 1 If reduced intra-SR buffer capacity was responsible for reduced [Ca] SRT in HF, one might expect the relatively unaltered fractional SR Ca 2ϩ release observed in HF (as above). Indeed, there is evidence suggesting that CSQ inhibits RyR opening (via triadin and junctin) and that Ca 2ϩ binding to CSQ may relieve that inhibitory effect. 24, 25, 28 Thus, if CSQ had been reduced (but [Ca 2ϩ ] SR normal), we might have anticipated enhanced fractional SR Ca 2ϩ release or even arrhythmogenic spontaneous SR Ca 2ϩ release. 25, [32] [33] [34] However, intra-SR Ca 2ϩ buffering was unaltered in HF, and this was consistent with our finding of unaltered CSQ expression (as seen in other HF studies 1 ).
Intra-SR Ca 2ϩ buffering properties in intact cardiac myocytes have been inferred only indirectly 20 but have not previously been measured in situ (in any cardiac myocytes). Here, we provide the first direct measurement of SR Ca 2ϩ buffering in intact myocytes by simultaneously measuring [Ca 2ϩ ] SR and [Ca] SRT . We found no difference of intra-SR Ca 2ϩ buffering properties or CSQ expression levels in HF versus control myocytes.
It is notable that for normal diastolic [Ca 2ϩ ] SR of 1 to 1.5 mmol/L, only Ϸ50% to 60% of the SR Ca 2ϩ content is bound to the endogenous buffer, with 40% to 50% as free [Ca 2ϩ ]. This may explain why complete knockout of cardiac CSQ did not result in drastic cardiac systolic dysfunction and that a 50% increase in SR volume provided substantial functional compensation. 34 It also emphasizes that bound and free [Ca 2ϩ ] in the SR are quantitatively comparable, a point not widely appreciated. Arrhythmogenesis seen in CSQ knockout mice may partly reflect the inhibitory regulatory role of CSQ on RyR gating (as above).
Sarcoplasmic Reticulum Volume in HF
In HF, myocyte volume is increased, but if SR volume fails to keep up with cell size, then the volume percentage of SR could reduce [Ca] SRT (in cellular and myofilament volume terms) even with unaltered [Ca 2ϩ ] SR . 16 One previous study reported unchanged SR volume percentage in a hypertrophic rat model. 35 Here, we did not directly measure SR volume, but we inferred that SR volume percentage was not substantially altered, based on other directly measured values. First, both diastolic [Ca 2ϩ ] SR and [Ca] SRT decreased in parallel in HF ( Figure 4B ), suggesting that a decreased volume percentage would not be required to explain the reduced free [Ca] SRT . Second, intra-SR Ca 2ϩ buffering properties were unaltered in HF (along with parallel reduction in [Ca 2ϩ ] SR and [Ca] SRT ). If SR volume percentage had gone down 30% (as did [Ca] SRT ) in HF, the [Ca 2ϩ ] SR should have been essentially unaltered in HF. This was clearly not the case ( Figure 4B ). We cannot rule out small SR volume percentage changes in HF, but detailed electron microscopic stereological studies would be required to directly test that.
Relevance to Human Heart Failure: Clinical Implications
Reduced [Ca] SRT in HF is a major factor in systolic dysfunction. Because we now know that the reduced [Ca] SRT is mainly attributable to reduced [Ca 2ϩ ] SR (at least in this HF model), it has key implications for therapeutic strategies. First, low [Ca 2ϩ ] SR in HF means that the driving force for SR Ca 2ϩ release ([Ca 2ϩ ] SR Ϫ[Ca 2ϩ ] i ) is lower, limiting SR Ca 2ϩ release rate throughout the cycle. Second, the low [Ca 2ϩ ] SR tends to decrease the fractional SR Ca 2ϩ release (attributable to the regulatory effect on RyR). This would further limit SR Ca 2ϩ release during systole. Notably, there may be adaptive changes that compensate for this effect (eg, RyR phosphorylation and sensitization to I Ca trigger). 5, 6, 15 However, these adaptations may not really benefit systolic function because of intrinsic autoregulation (where fractional release is enhanced, but [Ca] SRT is consequently further reduced), 10, 15 and the enhanced diastolic SR Ca 2ϩ leak concomitant with sensitized RyRs can be arrhythmogenic. For example, CaMKIIdependent RyR phosphorylation can enhance fractional SR Ca 2ϩ release 31 but also enhances diastolic SR Ca 2ϩ release events (sparks) and arrhythmogenic Ca 2ϩ waves. 26 Third, it is the reduced [Ca 2ϩ ] SR that limits [Ca] SRT in HF. Thus, if SERCA pumps can restore normal [Ca 2ϩ ] SR , then they will also restore [Ca] SRT . That is, the capacity is there, if net Ca 2ϩ uptake can be enhanced. In summary, we found that a decrease in [Ca 2ϩ ] SR is largely responsible for the decrease in [Ca] SRT in HF myocytes. This knowledge will be valuable in understanding how to improve SR Ca 2ϩ cycling in the failing heart. 
